Gayle Furgurson Wellborn
Known title: DirectorCIK: 0001712960
Associated companies
Transaction History
| HQY | ▲ Buy | Grant | 2,877 | $0 | 6/25/2026 | View on chart |
| HQY | ▲ Buy | Option Exercise | 2,439 | $115K | 5/28/2026 | View on chart |
| HQY | ▼ Sell | Open Market | 2,439 | $220K | 5/28/2026 | View on chart |
| HQY | ▲ Buy | Option Exercise | 4,339 | $219K | 12/12/2025 | View on chart |
| HQY | ▼ Sell | Open Market | 4,339 | $425K | 12/12/2025 | View on chart |
| HQY | ▲ Buy | Grant | 2,003 | $0 | 6/26/2025 | View on chart |
| HQY | ▲ Buy | Option Exercise | 5,297 | $250K | 7/9/2024 | View on chart |
| HQY | ▼ Sell | Open Market | 5,297 | $431K | 7/9/2024 | View on chart |
| HQY | ▲ Buy | Grant | 2,543 | $0 | 7/5/2024 | View on chart |
| HQY | ▲ Buy | Grant | 3,164 | $0 | 6/22/2023 | View on chart |
| HQY | ▼ Sell | Open Market | 5,237 | $325K | 12/14/2022 | View on chart |
| HQY | ▲ Buy | Grant | 2,996 | $0 | 6/23/2022 | View on chart |
| HQY | ▲ Buy | Grant | 727 | $0 | 2/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns
HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.
HealthEquity Appoints Moody's CFO to Board Amid AI Cash Concerns. HealthEquity has appointed Noémie Heuland, CFO of Moody's, to its board of directors. This governance move comes as market commentary highlights concerns regarding the company's cash position in the context of AI adoption. The stock is currently trading near its 52-week low, with an average analyst target price of $119.33.